Indeed, studies link MMR deficiency with reduced CR to platinum-based chemotherapy (Fink et al, 1998b; Strathdee et al, 2001; Gifford et al, 2004). This evidence concerns the gene MRC1 and hyperinsulinemic hypoglycemia, familial, 4.